Letellier B, Kremer M, Becker LJ, Andry V, Goumon Y, Leboulleux Q, Hener P, Inquimbert P, Couqueberg N, Waltisperger E, Yalcin I, Mouthon F, Droguerre M, Charvériat M, Barrot M

Pain. 2021 Mar 24;:

How to study anxiety and depression in rodent models of chronic pain?

Kremer M, Becker LJ, Barrot M, Yalcin I

Eur J Neurosci. 2021 01;53(1):236-270

Design and synthesis of 3-aminophthalazine derivatives and structural analogues as PDE5 inhibitors: anti-allodynic effect against neuropathic pain in a mouse model.

Bollenbach M, Lugnier C, Kremer M, Salvat E, Megat S, Bihel F, Bourguignon JJ, Barrot M, Schmitt M

Eur J Med Chem. 2019 Sep 1;177:269-290

A Dual Noradrenergic Mechanism for the Relief of Neuropathic Allodynia by the Antidepressant Drugs Duloxetine and Amitriptyline.

Kremer M, Yalcin I, Goumon Y, Wurtz X, Nexon L, Daniel D, Megat S, Ceredig RA, Ernst C, Turecki G, Chavant V, Théroux JF, Lacaud A, Joganah LE, Lelievre V, Massotte D, Lutz PE, Gilsbach R, Salvat E, Barrot M

J. Neurosci.. 2018 Nov 14;38(46):9934-9954

Antidepressants and gabapentinoids in neuropathic pain: Mechanistic insights.

Kremer M, Salvat E, Muller A, Yalcin I, Barrot M

Neuroscience. 2016 Dec 3;338:183-206

The antiallodynic action of pregabalin in neuropathic pain is independent from the opioid system.

Kremer M, Yalcin I, Nexon L, Wurtz X, Ceredig RA, Daniel D, Hawkes RA, Salvat E, Barrot M

Mol Pain. 2016 ;12: